STRUCTURAL STUDIES ON KEY DRUG TARGETS: HUMAN KINASES AND NTP-BINDING PROTEINS

关键药物靶点的结构研究：人激酶和 NTP 结合蛋白

• 批准号: 7598072
• 负责人: DIRKSEN E BUSSIERE
• 金额: $ 0.02万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-03-01 至 2008-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7598072
• 关键词: Active Sites; Bacterial Infections; Binding Proteins; Computer Retrieval of Information on Scientific Projects Database; Computer Simulation; Crystallography; Data Collection; Drug Delivery Systems; Funding; Grant; Hepatitis C virus; Human; Hypoxanthine Phosphoribosyltransferase; Institution; Lead; Pharmaceutical Preparations; Phosphotransferases; Process; Property; Proteins; Research; Research Personnel; Resources; Screening procedure; Series; Source; Structure; Time; United States National Institutes of Health; Virus Diseases; base; cancer therapy; design; drug discovery; novel; three dimensional structure

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Modern drug discovery incorporates a target-based approach, wherein a macromolecular drug target (typically a protein) is chosen. The three-dimensional structure of the target is determined, usually by x-ray crystallography, and the detailed three-dimensional coordinates of the target active site are used for in silico screening and the design of initial lead compounds. Subsequent target:lead-compound structures are used to guide the design of the next series of lead compounds. This process iterates until the lead compound has suitable properties and is of high enough quality to be a drug. Our current drug discovery efforts focus on novel targets for the treatment of cancer, bacterial diseases, and viral diseases, particularly hepatitis C virus. These research efforts require MAD/SAD data collection time in excess of the time provided to us by our PRT membership. This proposal outlines a request for additional MAD time to support our drug discovery efforts.

这个子项目是众多研究子项目之一